Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30
The origin of the polybasic furin cleavage site (FCS) of SARS-CoV-2 remains a central question in debates on the emergence of COVID-19. One hypothesis proposes a genetic relationship between the SARS-CoV-2 S1/S2 motif RRAR and the RRVR sequence found in the mouse-adapted MERS-CoV strain MERS-MA30. Here, we combined large-scale bioinformatic analysis with experimental virology to evaluate this scenario. Analysis of over 17 million SARS-CoV-2 genomes revealed that the S:684V substitution corresponding to RRVR occurred repeatedly but only sporadically, never became phylogenetically basal, and showed limited geographic and temporal spread. Using reverse genetics, we generated SARS-CoV-2 variants encoding RRVR and demonstrated that S:684V consistently reduced viral entry efficiency and competitive fitness in multiple cell systems, including human respiratory epithelial cultures. RRVR variants did not evolve toward RRAR but instead accumulated alternative substitutions. These findings do not support an evolutionary relationship between MERS-MA30 and the SARS-CoV-2 FCS.
Authors
- Christian Drosten (ORCID: https://orcid.org/0000-0001-7923-0519)
- Anja Richter
- Sarah M. Metzger (ORCID: https://orcid.org/0000-0001-7730-9733)
- Mark-Christian Jaboreck (ORCID: https://orcid.org/0000-0002-1528-2755)
- Kim C. Heimsch
- Terry C. Jones (ORCID: https://orcid.org/0000-0003-1120-9531)
- R Olmer
- Jenny I J Meier
- Nicolai Diegmüller
Institutions
- Cal Poly Humboldt (US)
- University of Cambridge (GB)
- Medizinische Hochschule Hannover (DE)
- Humboldt-Universität zu Berlin (DE)
- German Center for Infection Research (DE)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2026-06-29
- DOI
- https://doi.org/10.1073/pnas.2601806123
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bundesministerium für Bildung und Forschung
- European Health and Digital Executive Agency